Congenital Heart Disease Physical Activity Lifestyle Study V.2
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-25
SponsorJamie Jackson
About this trial
The Congenital Heart Disease Physical Activity Lifestyle Intervention Study (CHD-PALS) V.2 seeks to determine the efficacy of a lifestyle intervention program for adolescents and young adults (AYAs) with congenital heart disease (CHD). This trial was adapted from the original CHD-PAL trial to continue improving cardiovascular outcomes for transition-aged CHD survivors.
Eligibility criteria
Qualifiers
Between the ages of 15-25 years
Diagnosed with moderate or complex structural CHD
Actively receiving care from a cardiologist at Nationwide Children's Hospital (NCH) or Ohio State University (OSU)
Disqualifiers
Unable to speak and read proficiently in English
Have a diagnosis of a genetic syndrome that impacts multiple organ systems
Have cognitive impairments that would interfere with completing study measures
Have been engaged in a formal exercise program within the past 6 months,
Trial design
Treatments tested in this trial
- Physical Activity Monitoring
- Tailored Exercise Prescription
- Healthy Lifestyle Education
- Physical Activity Lifestyle Intervention Informed by the Theory of Planned Behavior
Treatment groups
144 Participants
are divided into 2 treatment groupsSponsors and collaborators
Jamie Jackson
Lead sponsor
Nationwide Children's Hospital
Sponsor institution
National Institute of Nursing Research (NINR)
Collaborator
Source ClinicalTrials.gov